Price Alert

GreenLight Biosciences (GRNAW)

NASDAQ: GRNAW · Real-Time Price · USD

0.02

-0.00 (-0.99%)

At close: Jul 21, 2023, 6:10 PM

GreenLight Biosciences Statistics

Share Statistics

GreenLight Biosciences has 0 shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	n/a
Shares Floating	n/a
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

The PE ratio is -0.93 and the forward PE ratio is null. GreenLight Biosciences's PEG ratio is -0.03.

PE Ratio	-0.93
Forward PE	n/a
PS Ratio	24.39
Forward PS	n/a
PB Ratio	3.24
P/FCF Ratio	-0.95
PEG Ratio	-0.03

Financial Ratio History

Enterprise Valuation

GreenLight Biosciences has an Enterprise Value (EV) of 168.12M.

EV / Sales	26.33
EV / EBITDA	-1.09
EV / EBIT	-1.23
EV / FCF	-1.03

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 1.67.

Current Ratio	2.01
Quick Ratio	2.01
Debt / Equity	1.67
Debt / EBITDA	-0.52
Debt / FCF	-0.49
Interest Coverage	-39.76

Financial Efficiency

Return on Equity is -347.58% and Return on Invested Capital is -128.36%.

Return on Equity	-347.58%
Return on Assets	-112.42%
Return on Invested Capital	-128.36%
Revenue Per Employee	$22.8K
Profits Per Employee	$-596.63K
Employee Count	280
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	1.09M
Effective Tax Rate	-0.66%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0, so GreenLight Biosciences's price volatility has been lower than the market average.

Beta	0
52-Week Price Change	n/a
50-Day Moving Average	0.02
200-Day Moving Average	0.1
Relative Strength Index (RSI)	54.41
Average Volume (20 Days)	n/a

Income Statement

In the last 12 months, GreenLight Biosciences had revenue of 6.38M and earned -167.06M in profits. Earnings per share was -1.27.

Revenue	6.38M
Gross Profit	6.38M
Operating Income	-163.92M
Net Income	-167.06M
EBITDA	-153.99M
EBIT	-161.84M
Earnings Per Share (EPS)	-1.27

Full Income Statement

Balance Sheet

The company has 68.1M in cash and 80.48M in debt, giving a net cash position of -12.38M.

Cash & Cash Equivalents	68.1M
Total Debt	80.48M
Net Cash	-12.38M
Retained Earnings	-420.64M
Total Assets	n/a
Working Capital	n/a

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -136.73M and capital expenditures -26.55M, giving a free cash flow of -163.28M.

Operating Cash Flow	-136.73M
Capital Expenditures	-26.55M
Free Cash Flow	-163.28M
FCF Per Share	-1.24

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -2567.65% and -2616.78%.

Gross Margin	100%
Operating Margin	-2567.65%
Pretax Margin	-2599.67%
Profit Margin	-2616.78%
EBITDA Margin	-2412.11%
EBIT Margin	-2567.65%
FCF Margin	-2557.61%

Dividends & Yields

GRNAW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	-107.27%
FCF Yield	-104.85%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for GRNAW.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a